N@N

Anthony Petrone Initiated (ADMA) at Strong Buy and Held Target at $5 on, Oct 13th, 2022

Anthony Petrone of Mizuho, Initiated "ADMA Biologics, Inc." (ADMA) at Strong Buy and Held Target at $5 on, Oct 13th, 2022.

Anthony has made no other calls on ADMA in the last 4 months.

There is 1 other peer that has a rating on ADMA. Out of the 1 peers that are also analyzing ADMA, 0 agree with Anthony's Rating of Hold.

This is the rating of the analyst that currently disagrees with Anthony

---

• Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $4 on, Monday, July 25th, 2022

Contributing Sources

---